The Next Decade of MPN Therapy: CALR Approaches, Novel Combinations, and the Evolution of Care with Dr. Lucia Masarova image

The Next Decade of MPN Therapy: CALR Approaches, Novel Combinations, and the Evolution of Care with Dr. Lucia Masarova

Apr 24, 2026
03:30PM - 04:30PM EDT
Online Event
Overview

Join HealthTree for MPN as Dr. Lucia Masarova explores the shift from symptom management to true disease modification through CALR-targeted therapies and novel combination regimens. This session provides a critical look at the next decade of MPN care, highlighting the latest data on deep molecular remissions and the emerging roles of novel therapies.

Agenda
3:30 PM
Introductions
Dalton Bean

Dalton introduces the agenda of the event and featured speaker Dr. Lucia Masarova

3:35 PM
Presentation
Lucia Masarova, MD

Dr. Masarova talks about CARL therapy for MPN patients

4:05 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators
Healthtree contact Dalton Bean

Dalton Bean

Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.
Healthtree contact Lucia Masarova, MD

Lucia Masarova, MD

Dr. Lucia Masarova is an Assistant Professor at the Leukemia Department at the MD Anderson Cancer Center. Her clinical and research focus is on myeloproliferative neoplasms, and she is particularly interested in developing novel therapies to address the complex needs of MPN patients.